Aortic Valve Market Report Provides a Comprehensive Analysis of Current & Future Market Trends, And Emerging Revenues for Business Development
The global aortic valve market is forecasted to attain revenue of $13.6 billion by 2025, according to P&S Market Research.
The market is mainly driven by increasing prevalence of valvular diseases, increasing demand for minimally invasive surgeries (MISs), rise in number of clinical trials for heart valves, and introduction of advanced implants.
On the basis of type of surgery, aortic valve market is segmented into MIS and open surgery. The adoption of these valves for MISs is expected to grow at a faster CAGR of 13.7% during the forecast period. MISs causes lesser trauma to the patient and facilitate quicker recovery than invasive procedures such as open-heart surgeries. Due to reduced prices and advantages, there is an increase in the adoption of minimally invasive procedures, which contribute in the growth of the market.
The key end user in the aortic valve market includes hospitals, and others. Among these, hospitals registered the larger share, of 76.3%, in the market in 2017, owing to increasing number of patient population with valvular diseases in the hospitals.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample
During the forecast period, the aortic valve industry is expected to witness the fastest growth in demand in Asia-Pacific (APAC), at a CAGR of 13.0%, owing to the presence of large number of patient population with cardiovascular diseases, rising number of aortic valve replacement surgeries, growing medical tourism, and continuously improving healthcare infrastructure.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aortic-valve-market
Moreover, economic development and rising healthcare expenditure are some of the factors that are expected to boost the APAC aortic valve market over the forecast period. Growing number of approvals for transcatheter valves by companies such as Edwards Lifesciences Corporation, Medtronic plc, and others is also expected to contribute in the growth of the market. For instance, in March 2018, LivaNova plc announced the first patient enrolment in the Perceval Valve clinical study for Chinese Registration (“PERFECT”) TRIAL. This pre-market, prospective, single-arm trial study is being conducted to demonstrate the safety and effectiveness of Perceval Valve.
Some of the other key players operating in the aortic valve market are Medtronic plc and Boston Scientific Corporation.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)